ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,949Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 198

$817K Total Retail Price of All Prescriptions

Rank: 19 out of 198

526 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 526 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 526 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,814 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 713 639 1 2
LISINOPRIL 562 489 2 6
LEVOTHYROXINE SODIUM 443 420 3 1
HYDROCODONE-ACETAMINOPHEN 437 253 S3 4 8
AMLODIPINE BESYLATE 434 388 5 4
OMEPRAZOLE 353 290 6 3
FUROSEMIDE 328 317 7 5
ATENOLOL 281 242 8 17
METOPROLOL SUCCINATE 231 199 9 11
CITALOPRAM HBR 219 193 10 20
TRAMADOL HCL 199 160 11 15
GLIMEPIRIDE 198 164 12 35
METFORMIN HCL 195 162 13 13
ZOLPIDEM TARTRATE 191 146 14 22
METOPROLOL TARTRATE 190 190 15 10
CELEBREX 172 144 16 59
HYDROCHLOROTHIAZIDE 165 162 17 16
WARFARIN SODIUM 164 144 18 7
DONEPEZIL HCL 159 145 19 28
ATORVASTATIN CALCIUM 153 142 20 12
TAMSULOSIN HCL 130 118 21 27
ALENDRONATE SODIUM 129 116 22 21
LOSARTAN POTASSIUM 117 107 23 18
CLOPIDOGREL 95 89 24 42
TRAZODONE HCL 91 24 25 50
RAMIPRIL 88 88 26 72
PREDNISONE 87 51 27 29
NAMENDA 87 73 27 33
OXYBUTYNIN CHLORIDE 86 68 29 89
ALLOPURINOL 82 76 30 23
GABAPENTIN 82 78 30 14
NASONEX 82 77 30 189
SYNTHROID 79 66 33 36
PLAVIX 78 77 34 66
SINGULAIR 77 58 35 106
POTASSIUM CHLORIDE 77 76 35 9
MELOXICAM 73 69 37 30
PANTOPRAZOLE SODIUM 72 66 38 31
BUSPIRONE HCL 71 47 39 132
EVISTA 69 69 40 104
CARVEDILOL 68 62 41 24
CYCLOBENZAPRINE HCL 67 30 R 42 67
CYMBALTA 63 48 43 48
LEVOFLOXACIN 62 53 44 81
NYSTATIN-TRIAMCINOLONE 62 58 44 260
AMOXICILLIN 61 44 46 130
ADVAIR DISKUS 61 55 46 47
JANUVIA 59 27 48 86
BUPROPION XL 58 56 49 269
CRESTOR 57 48 50 26
POLYETHYLENE GLYCOL 3350 56 47 51 41
PRADAXA 56 54 51 187
PROAIR HFA 53 39 53 80
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 42 53 90
PROPRANOLOL HCL 53 53 53 92
CLONIDINE HCL 53 49 53 52
AZITHROMYCIN 52 39 57 56
ISOSORBIDE MONONITRATE ER 51 40 58 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 51 58 38
VENLAFAXINE HCL ER 51 26 58 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.